Holista and GICC LLC have issued instructions to commence further tests on Path-Away® to assess its
efficacy against COVID-19 via the more rigorous direct inoculation method. This additional testing is
being conducted at Biosafety Laboratory approved by the Centers for Disease Control (“CDC” ) of the
United States. Results are expected to be released as soon as the testing procedure is completed
based on the current work schedule.
Does anybody know when the results are expected for this? Have I misread it somewhere or has it now been told? Cheers!
Holista CollTech joins forces with GICC to develop works first nasal sanitiser, page-1682
Add HCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.691M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 32051 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 80000 | 1 |
View Market Depth
| Last trade - 16.12pm 14/10/2024 (20 minute delay) ? |
| HCT (ASX) Chart |
Day chart unavailable